Search by Drug Name or NDC
NDC 00078-0855-26 CIPRO 2; 10 mg/mL; mg/mL Details
CIPRO 2; 10 mg/mL; mg/mL
CIPRO is a AURICULAR (OTIC) SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE.
MedlinePlus Drug Summary
Ciprofloxacin and hydrocortisone otic is used to treat outer ear infections in adults and children. Ciprofloxacin is in a class of medications called quinolone antibiotics. Hydrocortisone is in a class of medications called corticosteroids. The combination of ciprofloxacin and hydrocortisone works by killing the bacteria that cause infection and reducing swelling in the ear.
Related Packages: 00078-0855-26Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ciprofloxacin and Hydrocortisone Otic
Product Information
| NDC | 00078-0855 |
|---|---|
| Product ID | 0078-0855_9e49e1c4-271b-4d37-a644-9065cda81ae7 |
| Associated GPIs | 87991002401820 |
| GCN Sequence Number | 039806 |
| GCN Sequence Number Description | ciprofloxacin/hydrocortisone DROPS SUSP 0.2 %-1 % OTIC (EAR) |
| HIC3 | Q8F |
| HIC3 Description | OTIC PREPARATIONS,ANTI-INFLAMMATORY-ANTIBIOTICS |
| GCN | 82031 |
| HICL Sequence Number | 018392 |
| HICL Sequence Number Description | CIPROFLOXACIN HCL/HYDROCORTISONE |
| Brand/Generic | Brand |
| Proprietary Name | CIPRO |
| Proprietary Name Suffix | HC |
| Non-Proprietary Name | ciprofloxacin hydrochloride and hydrocortisone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION/ DROPS |
| Route | AURICULAR (OTIC) |
| Active Ingredient Strength | 2; 10 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020805 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0855-26 (00078085526)
| NDC Package Code | 0078-0855-26 |
|---|---|
| Billing NDC | 00078085526 |
| Package | 10 mL in 1 BOTTLE (0078-0855-26) |
| Marketing Start Date | 2022-03-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 34.8905 |
| Pricing Unit | ML |
| Effective Date | 2023-10-18 |
| NDC Description | CIPRO HC OTIC SUSPENSION |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis